. Author manuscript; available in PMC: 2015 Mar 1.

Published in final edited form as: Gynecol Oncol. 2014 Jan 23;132(3):542–550. doi: 10.1016/j.ygyno.2014.01.026

Table 5.

Relative risks of overall survival by log transformed CA125, WBC, differential counts and NLR among all cases.

	Multivariate HR (95%CL)¹		p	Multivariate HR (95%CI)²		p
CA125	1.10	(1.00,1.20)	0.05
WBC	0.99	(0.63,1.57)	0.97	0.92	(0.58,1.46)	0.73
Neutrophils	1.19	(0.83,1.72)	0.35	1.10	(0.75,1.60)	0.64
Lymphocytes	0.56	(0.40,0.80)	0.001	0.60	(0.42,0.85)	0.005
Monocytes	0.60	(0.17,2.14)	0.43	0.47	(0.13,1.70)	0.25
Eosinophils	1.00	(0.84,1.20)	0.98	1.01	(0.84,1.20)	0.95
Basophils	0.84	(0.66,1.08)	0.18	0.85	(0.66,1.08)	0.19
NLR	1.43	(1.13,1.81)	0.003	1.37	(1.06,1.76)	0.02

Adjusted for age (continuous), hospital (BWH, MGH), year of enrollment, histologic subtype (serous borderline, serous invasive, mucinous borderline, mucinous invasive, endometrioid, clear cell, other), grade (invasive, non invasive), stage (I, II, III, IV, unknown), optimal debulking status (no, yes, unknown), smoking status (never, former, current), and BMI (<20, 20–24.9, 25–29.9, ≥30).

Additionally adjusted for CA125 (continuous, log transformed).